retinopathy glp 1 GLP-1 Drugs and Ocular Disease: Between Neuroprotection and Risk Frontiers | Unlocking the potential

Youre Eating Less

An increasing number of patients treated with novel antidiabetic drugs, including glucagon-like-peptide-1 receptor agonists (GLP-1RA), dual glucose-dependent insulinotropic polypeptide receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors, are presenting in the perioperative...

Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to suggest drugs like Ozempic contribute to vision loss.

Wisp debuts its first-ever exclusive over-the-counter weight-loss supplement, designed to promote women's metabolic health

But certain limitations persist.